Skip to search formSkip to main contentSkip to account menu

CDK inhibitor AT7519M

Known as: CDKI AT7519, Cyclin-Dependent Kinase Inhibitor AT7519M 
An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases… 
National Institutes of Health

Search for papers about CDK inhibitor AT7519M

Search papers